30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective
Amit Sharma, Ingo G.H. Schmidt‐Wolf
Abstract
Emerging evidence from the numerous clinical trials involving cytokine-induced killer (CIK) cell therapy suggests that its optimization in combination with other contemporary cancer therapies in a complementary manner (rather than as competition) will be a key to combat cancer.
Topics & Concepts
Perspective (graphical)Cancer therapyKey (lock)MedicineClinical trialCell therapyCancerCellComputer scienceBiologyPathologyInternal medicineArtificial intelligenceComputer securityGeneticsCAR-T cell therapy researchImmune Cell Function and InteractionImmunotherapy and Immune Responses